Last update: Oct. 9, 2016

Migretil™

Ergotamine Tartrate (active ingredient of Migretil):

Decreased level of risk

New scientific evidences have driven the Apilam staff to update the level of risk associated to this product.
Former level of risk, which was High Risk probable, is now set to Low Risk probable.

Level of risk reviewed on May 1, 2019

High Risk for breastfeeding


Poorly safe. Evaluate carefully.
Use safer alternative or interrupt breastfeeding several T½.
Read the Comment.

Migretil is a tradename that contains several active ingredients in its composition:

Since each active ingredient of this product may have a different level of risk for breastfeeding, we establish that of the product with higher risk.

For more information (pharmacokinetics, references, ...) tap each active ingredient.

Note: The composition of certain tradenames varies in each country. Please, make sure this is the composition of the tradename you are looking for..

Alternatives

Belladona

Caffeine

We do not have alternatives.

Ergotamine Tartrate

Paracetamol

There are no alternatives because it has very low risk level..

Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.

Total visits

360

Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write to us at elactancia.org@gmail.com

e-lactancia is a resource recommended by Asociación Pro Lactancia Materna (APROLAM) from Mexico

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM